News

Filter by:

Showing 12 of 594 Results

October 8, 2024 General News

Acadia Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

September 26, 2024 General News

Acadia Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

September 23, 2024 General News

Catherine Owen Adams Succeeds Steve Davis as CEO of Acadia Pharmaceuticals

August 28, 2024 General News

Acadia Pharmaceuticals to Participate at Upcoming Investor Conferences

August 14, 2024 General News

Ryan Reynolds Announces More to Parkinson’s® Campaign

August 7, 2024 General News

Acadia Pharmaceuticals to Participate in the Canaccord Genuity 44th Annual Growth Conference

August 6, 2024 Earnings News

Acadia Pharmaceuticals Reports Second Quarter 2024 Financial Results and Operating Overview

July 24, 2024 General News

Acadia Pharmaceuticals to Announce Second Quarter Financial Results on August 6, 2024

July 18, 2024 General News

Clinical Data from Open-Label Extension LILAC-1™ and LILAC-2™ Studies Evaluating Long-Term Safety and Efficacy of DAYBUE™ (trofinetide) in Patients with Rett Syndrome Published in Med

June 18, 2024 General News

Acadia Pharmaceuticals Presents DAYBUE™ (trofinetide) Real-World Evidence and Additional Data in Rett Syndrome at the 2024 International Rett Syndrome Foundation (IRSF) Annual Scientific Meeting

May 17, 2024 General News

Acadia Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

May 15, 2024 General News

Acadia Pharmaceuticals Announces Launch of Magnolia’s Guide to Adventuring: A Groundbreaking Documentary Series Aiming to Raise Disease Awareness and Redefine Perceptions of Rett Syndrome

Load More Results